The Gross Margin of BioXcel Therapeutics Inc (BTAI) is 5.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 5.43% |
2023-12-31 | 8.70% |
2022-12-31 | 94.74% |